{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T12:41:35Z","timestamp":1649076095653},"reference-count":30,"publisher":"Sociedad Espanola de Patologia Digestiva (SEPD)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Esp Enferm Dig"],"published-print":{"date-parts":[[2018]]},"DOI":"10.17235\/reed.2018.5268\/2017","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T12:52:36Z","timestamp":1524055956000},"source":"Crossref","is-referenced-by-count":0,"title":["Long-term results of linaclotide in the treatment of constipation-type irritable bowel syndrome"],"prefix":"10.17235","volume":"110","author":[{"given":"Fernando","family":"Geijo Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"S\u00e1nchez Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor","family":"Marcos Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concepci\u00f3n","family":"Pi\u00f1eiro P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Beatriz","family":"Prieto Bermejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"\u00c1lvarez Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Velasco Guardado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rodr\u00edguez P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6910","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e318247157c"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.02.029"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.195"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.119446"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.18"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41211.x"},{"key":"ref7","unstructured":"7. Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel"},{"key":"ref8","unstructured":"Disorders. Gastroenterology. 2016 Feb 18. pii: S0016-5085(16)00222-5."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i22.6759"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.17235\/reed.2016.4352\/2016"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.17235\/reed.2016.4389\/2016"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0473-8"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2010.12.005"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2010.09.019"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2009.01385.x"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.08.017"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.255"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.254"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12123"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12089"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8612189"},{"key":"ref22","unstructured":"21. Lacy BE, Lembo AJ, Macdougall JE, Shiff SJ, Kurtz CB, Currie MG, et al."},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Responders vs clinical response: a critical analysis of data from linaclotide phase 3 clinical trials in IBS-C. Neurogastroenterol Motil. 2014 Mar;26(3):326-33.","DOI":"10.1111\/nmo.12264"},{"key":"ref24","unstructured":"22. Andresen V, Diemert S, Miehlke S, Beck E, Prechtl A, Layer P. Effectiveness and tolerability of linaclotide in the treatment of ibs-c in a real-world setting: results from a german non-interventional study. Disponible en https:\/\/uegw.congress-online.com\/guest\/IDe74b14611d0e7e\/AbstractView?ABSID=10829  \u00daltimo acceso 05 de junio 2017."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312388.213"},{"key":"ref26","unstructured":"24. Serrano B, Delgado-Aros S, Mearin F, Ciriza de los R\u00edos C,"},{"key":"ref27","unstructured":"Serra J, M\u00ednguez P\u00e9rez M, et al. Respuesta de los s\u00edntomas intestinales,"},{"key":"ref28","unstructured":"No intestinales y extradigestivos a linaclotida en pacientes con s\u00edndrome del intestino irritable con estre\u00f1imiento: la respuesta a las 4 semanas de tratamiento predice la respuesta mantenida [P 209]. Gastroenterol Hepatol. 2017;40(3):166."},{"key":"ref29","unstructured":"25. M\u00ednguez Cortes JM. Evaluaci\u00f3n de tratamiento con linaclotida en un hospital comarcal. P40. Disponible en https:\/\/www.sapd.es\/revista\/article.php?file=vol38_n5_reunion\/25  \u00daltimo acceso 26 de mayo 2017."},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/1740774515602688"}],"container-title":["Revista Espa\u00f1ola de Enfermedades Digestivas"],"original-title":[],"deposited":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T12:53:02Z","timestamp":1524055982000},"score":1,"resource":{"primary":{"URL":"https:\/\/online.reed.es\/fichaArticulo.aspx?iarf=684763746234-414275197162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":30,"URL":"https:\/\/doi.org\/10.17235\/reed.2018.5268\/2017","relation":{},"ISSN":["1130-0108"],"issn-type":[{"value":"1130-0108","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}